The National Institutes of Health is offering exploratory grants to promote translational research in developing new cancer therapies and preventive strategies targeted at specific molecular targets. These grants support pilot clinical trials exploring individual anticancer agents/modalities and their combinations, as well as patient monitoring and laboratory studies. Emphasis is placed on exploring complementary and alternative approaches for cancer prevention and treatment, including AIDS-associated malignancies and cancer-related nutritional interventions. The goal is to issue new awards within 6 months of grant application receipt. This grant opportunity falls under the NIH exploratory/developmental (R21) mechanism.
Opportunity ID: 44006
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | PAR-08-025 |
| Funding Opportunity Title: | Quick-Trials for Novel Cancer Therapies and Prevention: Exploratory Grants (R21) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Education Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.393 — Cancer Cause and Prevention Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Dec 05, 2008 |
| Last Updated Date: | – |
| Original Closing Date for Applications: | – Multiple Receipt Dates – See Link to Full Announcement for details. |
| Current Closing Date for Applications: | – Multiple Receipt Dates – See Link to Full Announcement for details. |
| Archive Date: | Dec 10, 2010 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | $250,000 |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education For profit organizations other than small businesses Private institutions of higher education Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Others (see text field entitled “Additional Information on Eligibility” for clarification) State governments Small businesses Public and State controlled institutions of higher education |
| Additional Information on Eligibility: | Foreign institutions are eligible to apply. Eligible agencies of the Federal Government can apply. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | -Purpose. This FOA is intended to promote translational research in new agent/modality development with timely exploitation of new cancer-relevant therapeutic and/or preventive strategies that involve defined molecular targets. Applications are solicited for pilot clinical trials exploring individual anticancer agents/modalities and/or their combinations in the context of specific molecular targets. Applicants may propose Phase 0, Phase I, Phase II, and/or other pilot cancer clinical trials. In addition, patient monitoring and laboratory correlative studies related to clinical trials may be proposed. Applications that explore complementary and alternative approaches for cancer prevention and/or treatment are also encouraged. Clinical trials proposed may be oriented on AIDS-associated malignancies and cancer-related nutritional interventions. Applicants must include the clinical protocol within the Appendix to ensure proper accelerated peer review with the goal of issuing new awards within 6 months of receipt of the grant application. -Mechanism of Support. This FOA will use the NIH exploratory/developmental (R21) grant mechanism for exploratory, pilot projects. Applicants planning to propose fully developed research projects supported by preliminary data should consider a related FOA (PA-07-356) that solicits applications for clinical therapeutic and preventive trials under the NIH research project (R01) grant mechanism. -Funds Available and Anticipated number of Awards: Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications; therefore, the anticipated number of awards is not known. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/pa-files/PAR-08-025.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
There are no related documents on this grant.
Packages
| Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| ADOBE-FORMS-A | Adobe-Forms-A | PKG00009354 | Dec 05, 2008 | Dec 31, 2009 | View | |
| ADOBE-FORMS-B | Use for submissions intended for due dates of January 25, 2010 and beyond | PKG00015512 | Dec 31, 2009 | Nov 09, 2010 | View |
Package 1
Mandatory forms
44006 RR_SF424-1.1.pdf
44006 RR_KeyPersonExpanded-1.1.pdf
44006 RR_OtherProjectInfo-1.1.pdf
44006 RR_PerformanceSite-1.1.pdf
44006 PHS398_CoverPageSupplement-1.1.pdf
44006 PHS398_ResearchPlan-1.1.pdf
44006 PHS398_Checklist-1.1.pdf
Optional forms
44006 PHS398_CoverLetter-1.1.pdf
44006 PHS398_ModularBudget-1.1.pdf
44006 RR_Budget-1.1.pdf
44006 RR_SubawardBudget-1.2.pdf
Package 2
Mandatory forms
44006 RR_SF424_1_2-1.2.pdf
44006 PerformanceSite_1_3-1.3.pdf
44006 RR_OtherProjectInfo_1_2-1.2.pdf
44006 RR_KeyPersonExpanded_1_2-1.2.pdf
44006 PHS398_CoverPageSupplement_1_4-1.4.pdf
44006 PHS398_ResearchPlan_1_3-1.3.pdf
44006 PHS398_Checklist_1_3-1.3.pdf
Optional forms
44006 PHS_CoverLetter_1_2-1.2.pdf
44006 PHS398_ModularBudget-1.1.pdf
44006 RR_Budget-1.1.pdf
44006 RR_SubawardBudget-1.2.pdf
Leave a Reply